These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38940005)

  • 1. Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.
    Peigh G; Zhou J; Rosemas SC; Roberts AI; Longacre C; Trinh K; Nayak T; Soderlund D; Passman RS
    Circulation; 2024 Jul; 150(5):350-361. PubMed ID: 38940005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.
    Chew DS; Li Z; Steinberg BA; O'Brien EC; Pritchard J; Bunch TJ; Mark DB; Patel MR; Nabutovsky Y; Greiner MA; Piccini JP
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e010304. PubMed ID: 35089799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization.
    Peigh G; Zhou J; Rosemas SC; Roberts AI; Longacre C; Nayak T; Schwab G; Soderlund D; Passman RS
    JACC Clin Electrophysiol; 2024 Apr; 10(4):718-730. PubMed ID: 38430088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
    Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
    Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads.
    Dinshaw L; Schäffer B; Akbulak Ö; Jularic M; Hartmann J; Klatt N; Dickow J; Gunawardene M; Münkler P; Hakmi S; Pecha S; Sultan A; Lüker J; Pinnschmidt H; Hoffmann B; Gosau N; Eickholt C; Willems S; Steven D; Meyer C
    J Cardiovasc Electrophysiol; 2019 May; 30(5):679-687. PubMed ID: 30821012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.
    Piccini JP; Passman R; Turakhia M; Connolly AT; Nabutovsky Y; Varma N
    Europace; 2019 Mar; 21(3):404-413. PubMed ID: 30462208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
    Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
    J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
    Hess PL; Greiner MA; Fonarow GC; Klaskala W; Mills RM; Setoguchi S; Al-Khatib SM; Hernandez AF; Curtis LH
    Clin Cardiol; 2012 Nov; 35(11):649-57. PubMed ID: 23070696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
    Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
    Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices.
    Steinberg BA; Li Z; O'Brien EC; Pritchard J; Chew DS; Bunch TJ; Mark DB; Nabutovsky Y; Greiner MA; Piccini JP
    Heart Rhythm; 2021 May; 18(5):709-716. PubMed ID: 33508517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices.
    Afzal MR; Kanmanthareddy A; Earnest M; Reddy M; Atkins D; Bommana S; Bartus K; Rasekh A; Han F; Badhwar N; Cheng J; Dibiase L; Ellis CR; Dawn B; Natale A; Lee RJ; Lakkireddy D
    Heart Rhythm; 2015 Jan; 12(1):52-9. PubMed ID: 25281005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation.
    Hayashi H; Iwasaki YK; Arai T; Mimuro R; Hachisuka M; Maru Y; Fujimoto Y; Oka E; Hagiwara K; Imori Y; Yamamoto T; Murata H; Yodogawa K; Takano H; Shimizu W
    Heart Vessels; 2021 May; 36(5):667-674. PubMed ID: 33221953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.
    van Velzen HG; Theuns DA; Yap SC; Michels M; Schinkel AF
    Am J Cardiol; 2017 Jan; 119(1):100-105. PubMed ID: 28247846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.